ÂÜÀòÂÒÂ×

Chris Raymond is a seasoned scientist and co-founder at Ripple Biosolutions, where efforts focus on pioneering advanced methods for early disease detection, particularly cancer. With a diverse background in both leadership and research roles, Chris served as Chief Scientific Officer at Salish Bioscience Inc. and Resolution Bioscience, where innovative capabilities for profiling solid tumor genomes through blood-based assays were developed. Earlier career experiences include senior research fellow positions at NuGEN Technologies and Merck, concentrating on product development and innovative assay development. Chris holds a PhD in Chemistry from the University of Oregon and a BS in Chemistry from the University of California, Santa Cruz.